1. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee (HICPAC), 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, June 2007.
2. Garner JS. Hospital Infection Control Practices Advisory Committee. Guideline for Isolation Precautions in Hospitals. Infect Control Hosp Epidemiol 1996:17:53-80.
3. OSHA. (Lack of) Universal Precautions. Accessed September 6, 2007.
4. APIC. Guideline for Infection Prevention and Control in Flexible Endoscopy. AM J Infection Control. 2000:(28); 138-55.
5. AORN. Recommended Practices For Cleaning Endoscopes and Endoscope Accessories" AORN Journal. February 2003.
6. American Society for Gastrointestinal Endoscopy (ASGE). Infection Control During Gastrointestinal Endoscopy: Guidelines for Clinical Application. Gastrointestinal Endoscopy. 1999. (49)836-841
7. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee (HICPAC), Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006. http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf
8. CDC. Recommendations for Preventing the Spread of Vancomycin Resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995; 44(No. RR-12); 1-14.
9. Boyce JM, Havill NL, Benedicte M. Frequency and Possible Infection Control Implications of Gastrointestinal Colonization with Methicillin-Resistant Staphylococcus aureus. Journal of Clinical Microbiology. Dec. 2005: (43); 5992-5995.
10. Mylonakis E, Go CH, Cuhna BA. Escherichia Coli Infections. Emedicine May 26, 2006. http://www.emedicine.com/med/topic734.htm
. Accessed September 17, 2007.
11. Centers for Disease Control and Prevention. Guidelines for Environmental Infection Control in Healthcare Facilities: Recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 2003;52(No. RR-10); 1-48.
12. Sehulster LM, Chinn RYW, Arduino MJ, et. al. Guidelines for Environmental Infection Control in Health Care Facilities: Recommendations from CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Chicago, IL; American Society for Healthcare Engineering/American Hospital Association; 2004.
13. JCAHO. 2007 Hospital/Critical Access Hospital National Patient Safety Goals. http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals.
Accessed September 2007.
14. Sanaka MR, Shah N, Mullen KD, et al. Afternoon Colonoscopies Have Higher Failure Rates than Morning Colonoscopies. Amer Journal of Gastroenterology. December 2006: (101); 2726-2730.
15. Data on File. Vortek Surgical, LLC. Indianapolis, IN.
16. Fordtran JS. Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial. Proc (Bayl Univ Med Cent). January 2006; 19(1): 3-12.
17. Phend C. Proton Pump Inhibitors Linked Anew to C. Difficile-Associated Disease. CMAJ 2006; 175:745-748.
18. Yearsley KA, Gilby LJ, Ramadas AV, et al. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Alimentary Pharmacology and Therapeutics 2006; 24(4):613-619.
19. CDC (2005). Severe Clostridium difficile-Associated Disease in Populations Previously at Low Risk-Four States, 2005. MMWR 54(47); 1201-1205.
20. Nurse.com. Hospital C. diff Infections Nearly Triple. June 4, 2007. www.nurse.com
. Accessed September 2007.
. Accessed September 6, 2007.
22. NNIS (2003). Am J Infect Control. (31); 481-498.
23. Poore R. E. Coli Infections. WebMD: June 27, 2006. http://www.webmd.com/a-to-z-guides/E-coli-infection-topic-overview
. Accessed September 10, 2007.
24. Kyne L, Hamel MB, Polavaram R. et al. Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile. CID 2002;34:346-353.
25. Suda KJ. Et al. Abstr Intersci Conf. Antimicrob Agents Chemother, 43. 2003: abstract no. K-734.